Kyle Dempsey
Direktor/Vorstandsmitglied bei OPTINOSE, INC.
Vermögen: 6 089 $ am 30.04.2024
Aktive Positionen von Kyle Dempsey
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OPTINOSE, INC. | Direktor/Vorstandsmitglied | 10.12.2021 | - |
| Independent Dir/Board Member | 10.12.2021 | - | |
| HLS THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 29.11.2022 | - |
| Independent Dir/Board Member | 29.11.2022 | - | |
| MVM Partners LLC | Private Equity Investor | 01.09.2017 | - |
GT Medical Technologies, Inc.
 GT Medical Technologies, Inc. Medical SpecialtiesHealth Technology GT Medical Technologies, Inc. engages in the design and development of a medical device for the treatment of brain tumors. It offers GammaTile Therapy, which is a surgically targeted radiation therapy which is placed at the end if a brain excision surgery and targets residual tumor cells. The company was founded by Heyoung McBride, Peter Nakaji, Emad Youssef, and Theresa Thomas in 2017 and is headquartered in Tempe, AZ. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Kyle Dempsey
Ausbildung von Kyle Dempsey
| Harvard Medical School | Doctorate Degree |
| Bowdoin College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 7 |
| Kanada | 2 |
Operativ
| Director/Board Member | 3 |
| Independent Dir/Board Member | 2 |
| Private Equity Investor | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| OPTINOSE, INC. | Health Technology |
| HLS THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| MVM Partners LLC | Finance |
GT Medical Technologies, Inc.
GT Medical Technologies, Inc. Medical SpecialtiesHealth Technology GT Medical Technologies, Inc. engages in the design and development of a medical device for the treatment of brain tumors. It offers GammaTile Therapy, which is a surgically targeted radiation therapy which is placed at the end if a brain excision surgery and targets residual tumor cells. The company was founded by Heyoung McBride, Peter Nakaji, Emad Youssef, and Theresa Thomas in 2017 and is headquartered in Tempe, AZ. | Health Technology |
- Börse
- Insiders
- Kyle Dempsey
- Erfahrung